Table 3. Frequency of genotypes of six CALCRL snps in PACG patients and controls.
| dbSNP ID | Genotype | Control n (%) | APACG n (%) | p Value | CPACG n (%) | p Value |
|---|---|---|---|---|---|---|
|
rs7591567 |
CC |
5 (2.4%) |
3 (2.8%) |
0.779 |
2 (2%) |
0.368 |
| |
CT |
53 (25.9%) |
32 (29.4%) |
|
33 (33.7%) |
|
| |
TT |
147 (71.7%) |
74 (67.9) |
|
63 (64.3%) |
|
|
rs3771073 |
CC |
4 (2%) |
2 (1.8%) |
0.343 |
1 (1%) |
0.509 |
| |
CG |
57 (27.8%) |
39 (35.8%) |
|
33 (33.7%) |
|
| |
GG |
144 (70.2%) |
68 (62.4%) |
|
64 (65.3%) |
|
|
rs9288141 |
AA |
128 (62.4%) |
68 (62.4%) |
0.816 |
61 (62.2%) |
0.951 |
| |
AG |
72 (35.1%) |
37 (33.9%) |
|
34 (34.7%) |
|
| |
GG |
5 (2.4%) |
4 (3.7%) |
|
3 (3.1%) |
|
|
rs1157699 |
CC |
138 (67.3%) |
57 (52.3%) |
0.028 |
60 (61.2%) |
0.415 |
| |
CT |
60 (29.3%) |
48 (44%) |
|
32 (32.7%) |
|
| |
TT |
7 (3.4%) |
4 (3.7%) |
|
6 (6.1%) |
|
|
rs6759535 |
CC |
95 (46.3%) |
56 (51.4%) |
0.469 |
50 (51%) |
0.742 |
| |
CT |
97 (47.3%) |
44 (40.4%) |
|
42 (42.9%) |
|
| |
TT |
13 (6.3%) |
9 (8.3%) |
|
6 (6.1%) |
|
|
rs840617 |
AA |
18 (8.8%) |
12 (11%) |
0.494 |
5 (5.1%) |
0.488 |
| |
AT |
79 (38.5%) |
35 (32.1%) |
|
37 (37.8%) |
|
| TT | 108 (52.7%) | 62 (56.9%) | 56 (57.1%) |